Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy
- PMID: 23356871
- DOI: 10.3109/00016489.2012.749520
Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy
Abstract
Conclusion: Intratympanic steroid therapy (IT-S) was as effective as systemic steroid therapy (SST) or combined therapy (CT) and could be considered a first-line therapeutic modality for idiopathic sudden sensorineural hearing loss (SSNHL). Due to its known safety and efficacy, IT-S will be particularly suitable for patients with SSNHL who have chronic diseases such as diabetes mellitus, hypertension, or chronic renal failure.
Objectives: Systemic high dose steroid therapy is the main therapeutic modality for SSNHL. Comparable therapeutic efficacies for IT-S and CT with SST and IT-S for SSNHL have been reported recently. We compared the efficacy of IT-S, SST, and CT for treating SSNHL.
Methods: A retrospective, multicenter study investigating the therapeutic efficacy of SST, IT-S, and CT for SSNHL was designed and involved 735 patients with idiopathic SSNHL who were diagnosed and treated at seven tertiary referral medical centers of the Catholic University of Korea between 2007 and 2011. Patients were divided into three groups according to the treatment methods they received: IT-S group, SST group, and CT group (SS plus IT-S). Hearing was evaluated by pure tone audiogram performed before initial treatment and at 4 weeks following the final treatment. More than a 10 dB HL decrease in average air conduction threshold of hearing at 500, 1000, 2000, and 3000 Hz was defined as improved hearing.
Results: Among 735 patients with SSNHL, 94 were included in the IT-S group, 444 in the SST, and 197 in the CT group. Age, gender, interval from disease onset to start of treatment, and initial hearing level were not different among the three groups. Patients who had concomitant medical disorders such as diabetes mellitus, hypertension, or chronic renal failure were more frequently treated with IT-S. No difference in the level of hearing gain or ratio of hearing improvement was observed among the three groups (p = 0.147 and p = 0.067, respectively).
Similar articles
-
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15. Laryngoscope. 2007. PMID: 17202923 Review.
-
Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.Otol Neurotol. 2011 Jul;32(5):774-9. doi: 10.1097/MAO.0b013e31821fbdd1. Otol Neurotol. 2011. PMID: 21646929 Clinical Trial.
-
Steroid-based treatments for patients with total sudden sensorineural hearing loss.Acta Otolaryngol. 2015 Sep;135(9):907-13. doi: 10.3109/00016489.2015.1034881. Epub 2015 Apr 10. Acta Otolaryngol. 2015. PMID: 25857447
-
Systemic steroid versus combined systemic and intratympanic steroid treatment for sudden sensorineural hearing loss.J Craniofac Surg. 2013 Mar;24(2):432-4. doi: 10.1097/SCS.0b013e31828014e7. J Craniofac Surg. 2013. PMID: 23524709
-
Effectiveness of Steroid Treatment for Sudden Sensorineural Hearing Loss: A Meta-analysis of Randomized Controlled Trials.Ann Pharmacother. 2020 Oct;54(10):949-957. doi: 10.1177/1060028020908067. Epub 2020 Mar 4. Ann Pharmacother. 2020. PMID: 32126823
Cited by
-
Combination of Pulse Steroid with Intratympanic Injections in Sudden Sensorineural Hearing Loss.Iran J Otorhinolaryngol. 2021 Jan;33(114):9-13. doi: 10.22038/ijorl.2020.43887.2452. Iran J Otorhinolaryngol. 2021. PMID: 33654685 Free PMC article.
-
Systemic effects of intratympanic dexamethasone therapy.Endocr Connect. 2014 Sep;3(3):127-31. doi: 10.1530/EC-14-0076. Epub 2014 Jul 23. Endocr Connect. 2014. PMID: 25055818 Free PMC article.
-
Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial.Eur Arch Otorhinolaryngol. 2018 Jan;275(1):103-110. doi: 10.1007/s00405-017-4803-5. Epub 2017 Nov 22. Eur Arch Otorhinolaryngol. 2018. PMID: 29168028 Clinical Trial.
-
Steroids for idiopathic sudden sensorineural hearing loss.Cochrane Database Syst Rev. 2013 Jul 2;2013(7):CD003998. doi: 10.1002/14651858.CD003998.pub3. Cochrane Database Syst Rev. 2013. PMID: 23818120 Free PMC article.
-
Hearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols.Otol Neurotol. 2017 Jan;38(1):19-30. doi: 10.1097/MAO.0000000000001254. Otol Neurotol. 2017. PMID: 27779563 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous